Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
A reasonable candidate is someone who: Is already following a structured, clinician-supervised nutrition and activity plan Has a documented B12 deficiency or a condition that impairs B12 absorption Cannot tolerate GLP-1 medications, or is not a candidate for them Declines prescription pharmacotherapy and wants a non-stimulant, non-surgical adjunct Understands because the clinician has said so plainly that the injection is a supporting player A poor candidate is someone who wants the shot instead of the program
The typical adult dosage is 0.25 mL to 2 mL per dose, depending on the severity of the deficiency or the clinical indication
Achilles Tendon Rupture: The Achilles tendon transection model produces the largest body of BPC-157 evidence, with histological and biomechanical improvements documented across multiple published rat studies at 7, 14, and 21-day post-injury intervals
Non-alcoholic steatohepatitis (NASH): where are we now and where are we going
This typically resolves within a day or two
US$ 20.18
US$ 23.35
US$ 23.77
US$ 22.32
US$ 21.86
US$ 28.09
